We estimate Pfizer’s valuation to be $32 per share, indicating a solid nearly 40% upside potential. At its current price of $23, Pfizer stock is trading at just 8 times trailing earnings of $2. ...

Transparency Talks will bring together leaders from Model N, Pfizer and Global Pricing Innovations (GPI) to explore state drug pricing laws and regulations, as well as facilitate a discussion on ...

Let’s examine the loopholes, and how the companies have exploited them. Pfizer never said it would cut drug prices for Trump. Instead, the company said it would “defer” price increases on 41 ...

Pfizer is planning to raise prices on 41 drugs in January, even after agreeing to defer the price hikes under heavy pressure from President Donald Trump. CNN values your feedback 1.

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug.

“Pfizer & others should be ashamed that they have raised drug prices for no reason,” he tweeted. Pfizer agreed to temporarily roll back price hikes, but by fall, then-Pfizer CEO Ian Read told ...

Ian Read, CEO of New York City-based Pfizer, recently shared his thoughts on high drug prices, the Food and Drug Administration and President Donald Trump's administration in an interview with ...

The laws are designed to keep a check on drug prices, and one expert told Barron’s a ruling in Pfizer's favor “would be a major earthquake” for the industry.

WASHINGTON – Senators challenged top executives of seven pharmaceutical companies on the spiraling costs of prescription drugs. The CEOs of Pfizer, Merck, AbbVie, AstraZeneca, Bristol-Myers ...

Pfizer's $225K Price for Heart Drug Tafamidis Slammed. Patrice Wendling. ... "Based on current regulations, we are limited in how we can help Medicare patients reduce their out-of-pocket costs.

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including Ozempic, drugs for HIV, cancer and many others.

Pfizer is planning to raise prices on 41 drugs in January, even after agreeing to defer the price hikes under heavy pressure from President Donald Trump. CNN values your feedback 1.